Extended Data Fig. 6: Percent changes in ALT (a) and AST (b) over time. | Nature Medicine

Extended Data Fig. 6: Percent changes in ALT (a) and AST (b) over time.

From: Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

Extended Data Fig. 6

Data presented are estimate mean (SE). Error bars indicate SE. Baseline values were calculated using an ANOVA, post-baseline measures were calculated from an MMRM, all statistical tests were two sided at a significance level of 0.05. ANOVA, analysis of variance; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MMRM, mixed model for repeated measures; No., number of patients with baseline and post-baseline value at the specified time point; TZP, tirzepatide; SE, standard error; SFU, safety follow up.

Back to article page